Dealpath vs Buildout: Acquisitions Pipeline vs Brokerage Deal Management (2026)

Search "Dealpath vs Buildout" and you'll find them lumped together as "CRE deal management software." That framing is misleading. They share a category label, but they live on opposite sides of the transaction. Dealpath is a buy-side acquisitions pipeline — it tracks deals from sourcing through diligence to close for investors, developers, and lenders. Buildout is a sell-side brokerage platform — it builds offering memorandums, syndicates listings, and manages the broker's marketing and CRM workflow.

So the real question is rarely "which one wins." It's "which side of the deal am I on?" If you're an acquisitions team chasing assets, Dealpath is the natural home. If you're a brokerage marketing properties to buyers, Buildout is built for you. The interesting cases are the firms that touch both — vertically integrated operators, investment sales shops that also acquire — where you genuinely have to choose a center of gravity.

A note on positioning: NextAutomation is not a competitor to either tool, and we're not going to pretend otherwise. We're the AI/automation layer that feeds whichever pipeline you run — sourcing and diligence intake on the Dealpath side, OM and listing data on the Buildout side. This comparison is objective first; the automation angle comes at the end.

The Core Distinction: Buy-Side vs Sell-Side

Everything else follows from this. Dealpath optimizes for the buyer's job — evaluating opportunities, running diligence, and getting to an investment decision. Buildout optimizes for the seller's broker — packaging a property, getting it in front of qualified buyers, and managing the marketing pipeline.

If that table answers your question, you're done — the tools rarely overlap in a way that forces a head-to-head. For connection details on each platform, see our Dealpath integration and Buildout integration pages. The rest of this guide is for the firms where it isn't that clean.

Buyer Decision Criteria

Before you demo either platform, get honest about five questions. They'll tell you which tool — and which side — you're actually buying for.

• 1. Are you acquiring or marketing? The single most decisive question. Acquisitions teams pulling in deals need pipeline and diligence (Dealpath). Brokers pushing deals out need marketing and OMs (Buildout). Get this wrong and the tool fights your workflow daily.
• 2. How structured is your diligence? If your IC process has repeatable checklists, document requirements, and multi-person deal teams, Dealpath's structured diligence is its whole reason to exist. Buildout has no real diligence layer — that's not its job.
• 3. How much do you live in OMs and flyers? If you produce dozens of branded offering memorandums and listing flyers a year, Buildout's templated OM and syndication engine is a genuine time-saver. Dealpath produces no marketing collateral.
• 4. What does your CRM need to do? Buildout's CRM is broker-relationship and prospect-marketing oriented (buyers, sellers, email campaigns). Dealpath's deal records are investment-pipeline oriented (sponsors, brokers as deal sources, deal status). Different definitions of "contact."
• 5. How important is API/automation access today? Buildout exposes a native public API and Zapier; you can wire data flows yourself. Dealpath's API is partner-gated — real and well-supported, but you go through their partner program. If self-serve integration is a near-term priority, that difference matters.

Honest Head-to-Head: Winners by Use Case

Because these tools serve opposite sides, the honest answer is a winner per use case, not an overall champion.

The pattern is clean: Dealpath wins the buy-side decision and diligence work; Buildout wins the sell-side marketing and CRM work. Neither is a substitute for the other, and the firms that try to force one into the other's role end up frustrated. A vertically integrated operator that both sources and sells will often run both, with a clear primary depending on where its team spends the most time.

Lifecycle Fit: Where Each Tool Lives

Map both tools onto the CRE deal lifecycle and the boundary is obvious. They hand off to each other at the transaction, they don't compete across it.

• Sourcing: Dealpath captures inbound deals into a structured pipeline. Buildout is the source — it's where the broker's OM and listing originate. The buyer's Dealpath record often starts from the seller's Buildout-generated OM.
• Underwriting: Dealpath territory — it ties deal records to ARGUS and Excel models and tracks the analysis. Buildout doesn't underwrite.
• IC & Diligence: Dealpath owns this layer — checklists, document rooms, deal-team sign-offs, status tracking toward an investment-committee decision.
• Marketing & Disposition: Buildout owns this layer — OM generation, listing syndication, buyer outreach, and the sell-side CRM that runs a marketing campaign to close.
• Capital Raise: Neither tool. This is where dedicated investor portals come in — see our comparison of acquisitions pipeline vs. investor management in Best CRE deal management software.
• Asset Management & LP Reporting: Neither tool's domain. Dealpath closes its job at acquisition; Buildout closes its job at sale. Asset-management CRMs like VTS and fund-admin platforms pick up from here.

The Adjacent Tools You Should Also Weigh

"Dealpath vs Buildout" rarely surfaces in isolation. Depending on your side of the deal, three other platforms belong in the evaluation.

VTS is the leasing and asset-management CRM standard. If your real need is tracking tenants, lease events, and asset-level performance after you own the building — not the pre-close acquisitions pipeline — VTS, not Dealpath, is the right comparison. We break down the buy-side-pipeline-vs-asset-CRM question in our deal management guide.

Apto is a Salesforce-built brokerage CRM that overlaps Buildout on the relationship-management side. Brokers weighing Buildout for its OM and marketing engine often weigh Apto for deeper CRM and pipeline; some firms run both, with Buildout for marketing collateral and Apto for the contact graph.

Crexi is the marketplace where many Buildout listings end up. It's a distribution channel and a data/comps source rather than a deal-management workspace, but it's part of the sell-side picture — and increasingly a buy-side sourcing channel. For the full stack across all of these layers, see The Complete CRE Software Stack.

Where AI Changes the Answer

Here's the reframe that matters most: the choice between Dealpath and Buildout is about which workflow you run — but the painful, manual part of both workflows is the same, and it's the part AI automation eliminates. Neither tool fills itself.

On the Dealpath (buy-side) path, the bottleneck is getting deals into the pipeline and through diligence. Inbound OMs arrive as PDFs in email; an analyst keys the property, rent roll, and asking terms into a deal record by hand; diligence documents pile up in a data room waiting to be read. An AI deal-sourcing agent reads inbound OMs, scores them against your acquisition criteria, and pre-populates the deal record — so the pipeline tool you're paying for is full of clean, screened deals instead of waiting on data entry.

On the Buildout (sell-side) path, the bottleneck is keeping property, contact, and listing data consistent across the OM, the CRM, the marketplace listing, and your accounting/PM system. A CRM sync hub keeps Buildout's records in step with your other systems automatically — so a price change or a new contact propagates everywhere instead of being re-typed in four places.

The principle is the same one we apply across the stack: automation sits on top of the tool you chose, reading its outputs and feeding its inputs. You don't replace Dealpath or Buildout to get AI value — you stop paying analysts to do the data entry that makes either one worth having. If you want to map which automations pay back fastest for your side of the deal, our free roadmap call is the place to start.